12:00 AM
 | 
Oct 28, 2003
 |  BC Extra  |  Company News

Chiron, Pfizer HCV deal

CHIR non-exclusively licensed to PFE rights to research, develop and commercialize therapeutics against certain hepatitis C...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >